<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04966858</url>
  </required_header>
  <id_info>
    <org_study_id>2R01HD082166-06A1</org_study_id>
    <secondary_id>20-32551</secondary_id>
    <secondary_id>R01HD082166</secondary_id>
    <secondary_id>HD082166</secondary_id>
    <secondary_id>P0547076</secondary_id>
    <nct_id>NCT04966858</nct_id>
  </id_info>
  <brief_title>Individualized Study of Refeeding to Optimize iNpatient Gains</brief_title>
  <acronym>i-STRONG</acronym>
  <official_title>Renewal of the Multi-center Randomized Controlled Trial of Refeeding in Anorexia Nervosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of the trial is to compare the efficacy and safety of Individualized&#xD;
      Caloric Refeeding (ICR) to the new standard of care, Higher Calorie Refeeding (HCR), in&#xD;
      hospitalized patients with atypical anorexia nervosa (AAN), and clinical remission over one&#xD;
      year of follow-up.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atypical Anorexia Nervosa (AAN) is a new diagnosis describing patients with malnutrition and&#xD;
      significant weight loss yet &quot;normal&quot; weight. These patients responded poorly to HCR, the&#xD;
      superior refeeding treatment in the parent trial, which was designed for low-weight patients&#xD;
      with typical AN. The proposed trial will examine the safety and efficacy of a new treatment&#xD;
      for AAN with the potential to improve treatment outcomes for this diverse and growing patient&#xD;
      population. The major finding motivating the proposed trial is that participants with AAN&#xD;
      gained weight 40 percent slower and required 3.0 additional days in hospital to restore&#xD;
      medical stability on HCR, as compared to AN. The research team has developed Individualized&#xD;
      Caloric Refeeding (ICR), which doses calories to weight consistent with other pediatric&#xD;
      treatments (e.g. medication).&#xD;
&#xD;
      The primary purpose of the proposed trial is to compare the efficacy and safety of ICR to the&#xD;
      new standard of care (HCR) in hospitalized patients with AAN. The investigators hypothesize&#xD;
      that ICR will restore medical stability faster than HCR with no increase in electrolyte&#xD;
      abnormalities. After hospitalization, the major barrier to care in AAN is lack of consensus&#xD;
      on clinical remission and whether these formerly overweight patients should gain weight to&#xD;
      recover. The research team will examine metabolic, hormonal and psychological markers during&#xD;
      long-term follow-up, toward the goal of developing a definition of clinical remission in AAN.&#xD;
&#xD;
      Design Summary: Randomized controlled trial in N=74 participants age 12-24 with AAN,&#xD;
      consented upon hospital admission, randomly assigned to ICR or HCR, followed daily in&#xD;
      hospital and at 3, 6, 9 and 12 mo.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">April 14, 2026</completion_date>
  <primary_completion_date type="Anticipated">November 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be recruited upon hospital admission at the University of California, San Francisco (UCSF) and Stanford and randomly assigned to Individualized Caloric Refeeding (ICR) or Higher Calorie Refeeding (HCR) for the duration of the hospitalization. Treatment ends at hospital discharge with open follow-up for one year. Participants followed daily in hospital and at 3mo, 6mo, 9mo, and 12mo post-discharge.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Treatments are not to be blinded, since both the patients and clinicians who work with this population are highly skilled at estimating kcal and would be able to determine group assignment by simply viewing meal trays.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Achieve Medical Stability in Hospital</measure>
    <time_frame>Inpatient hospitalization from day of admission to day of discharge, average 1-2 weeks</time_frame>
    <description>Medical stability will be adjudicated by a five-point index: (1) 24 hour heart rate of 45 beats/min or more, (2) systolic blood pressure of 90 millimeters of mercury (mmHg) or more, (3) temperature of 35.6° C or more, (4) orthostatic increase in heart rate of 35 beats/min or less, (5) orthostatic change in systolic blood pressure of 20 mmHg or less.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of low serum electrolytes during refeeding in hospital</measure>
    <time_frame>Inpatient hospitalization from day of admission to day of discharge, average 1-2 weeks</time_frame>
    <description>Incidence of low electrolytes will be defined as: (1) hypophosphatemia less than 3 milligrams per deciliter (mg/dL), (2) hypomagnesaemia less than 1.8 mg/dL, and (3) hypokalemia less than 3.5 milliequivalent per liter (mEq/L) during hospitalization.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Percentage median BMI (mBMI) Over 12 Months</measure>
    <time_frame>12 months post-study hospitalization</time_frame>
    <description>Measured BMI will be divided by the mBMI for age and sex per national growth data to give the percentage mBMI.</description>
  </other_outcome>
  <other_outcome>
    <measure>Eating Disorder Examination Questionnaire (EDE-Q) Score Over 12 Months</measure>
    <time_frame>12 months post-study hospitalization</time_frame>
    <description>The EDE-Q will be self-administered; scores range from 1 to 6, with higher scores indicating greater severity and a worse outcome.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Atypical Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>Individualized Caloric Refeeding (ICR)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Starting 50 kcal/kg/d, increasing by 200 kcal/d to goal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Higher Calorie Refeeding (HCR)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Starting 2000 kcal/d, increasing by 200 kcal/d to goal</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Individualized Caloric Refeeding (ICR)</intervention_name>
    <description>Meal-based refeeding in hospital, starting at 50 calories per kilogram of body weight, and increasing by 200 calories per day until caloric goal achieved</description>
    <arm_group_label>Individualized Caloric Refeeding (ICR)</arm_group_label>
    <other_name>ICR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Higher Calorie Refeeding (HCR)</intervention_name>
    <description>Meal-based refeeding in hospital, starting at 2000 calories per day, and increasing by 200 calories per day until caloric goal achieved</description>
    <arm_group_label>Higher Calorie Refeeding (HCR)</arm_group_label>
    <other_name>HCR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 12-24 yrs&#xD;
&#xD;
          -  Meets Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for AAN&#xD;
&#xD;
          -  Hospitalized with medical instability, as defined by:&#xD;
&#xD;
               1. night time heart rate (HR) &lt;45 bpm,&#xD;
&#xD;
               2. systolic blood pressure (SBP) &lt;90 mmHg,&#xD;
&#xD;
               3. temperature &lt;35.6° C,&#xD;
&#xD;
               4. orthostatic Δ HR &gt;35 bpm, or&#xD;
&#xD;
               5. orthostatic Δ SBP &gt;20 mmHg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Bulimia nervosa&#xD;
&#xD;
          -  Current pregnancy&#xD;
&#xD;
          -  Chronic disease (e.g. immune, renal disease)&#xD;
&#xD;
          -  Acute/active suicidality or psychosis&#xD;
&#xD;
          -  Hospital admissions for refeeding in the prior 6 mo.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea K Garber, RD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neville H Golden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Garber, PHD, RD</last_name>
    <phone>415-514-2180</phone>
    <email>andrea.garber@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Siena Vendlinski, BS</last_name>
    <phone>510-928-9368</phone>
    <email>siena.vendlinski@ucsf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford University Lucille Packard Children's Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Neville H Golden, MB, MD</last_name>
      <phone>650-736-9557</phone>
      <email>ngolden@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Anna Kreiter, PsyD</last_name>
      <email>akreiter@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Neville H Golden, MB, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco Benioff Children's Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 8, 2021</study_first_submitted>
  <study_first_submitted_qc>July 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Malnutrition</keyword>
  <keyword>Refeeding</keyword>
  <keyword>Nutritional Rehabilitation</keyword>
  <keyword>Adolescent Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

